Advertisement

Topics

Bayer, J&J win third U.S. trial over Xarelto bleeding risk

13:41 EDT 18 Aug 2017 | Reuters

(Reuters) - A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the third case to go to trial out of thousands of lawsuits claiming the drugmakers' blood thinner Xarelto led to severe internal bleeding.

Original Article: Bayer, J&J win third U.S. trial over Xarelto bleeding risk

NEXT ARTICLE

More From BioPortfolio on "Bayer, J&J win third U.S. trial over Xarelto bleeding risk"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...